Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Neuropeptides ; 61: 77-85, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27932062

RESUMO

Early-life stress adversely affects the development of the brain, and alters a variety of behaviors such as pain in later life. In present study, we investigated how early-life stress (maternal separation or MS) can affect the nociceptive response later in life. We particularly focused on the role of oxytocin (OT) in regulating nociception in previously exposed (MS during early postnatal development) mice that were subjected to acute stress (restraint stress or RS). Further, we evaluated whether such modulation of pain sensation in MS mice are regulated by shared mechanisms of the OTergic and opioidergic systems. To do this, we assessed the underlying systems mediating the nociceptive response by administrating different antagonists (for both opioid and OTergic systems) under the different experimental conditions (control vs MS, and control plus RS vs MS plus RS). Our results showed that MS increased pain sensitivity in both tail-flick and hot-plate tests while after administration of OT (1µg/µl/mouse, i.c.v) pain threshold was increased. Atosiban, an OT antagonist (10µg/µl/mouse, i.c.v) abolished the effects of OT. While acute RS increased the pain threshold in control (and not MS) mice, treating MS mice with OT normalized the pain response to RS. This latter effect was reversed by atosiban and/or naltrexone, an opioid antagonist (0.5µg/µl/mouse, i.c.v) suggesting that OT enhances the effect of endogenous opioids. OTergic system is involved in mediating the nociception under acute stress in mice subjected to early-life stress and OTergic and opioidergic systems interact to modulate pain sensitivity in MS mice.


Assuntos
Privação Materna , Ocitocina/fisiologia , Limiar da Dor/fisiologia , Dor/fisiopatologia , Estresse Psicológico/fisiopatologia , Analgésicos Opioides/farmacologia , Animais , Feminino , Antagonistas de Hormônios/farmacologia , Masculino , Camundongos , Naltrexona/farmacologia , Dor/metabolismo , Limiar da Dor/efeitos dos fármacos , Estresse Psicológico/metabolismo , Vasotocina/análogos & derivados , Vasotocina/farmacologia
2.
Brain Res Bull ; 124: 150-63, 2016 06.
Artigo em Inglês | MEDLINE | ID: mdl-27129671

RESUMO

Tropisetron, a 5-HT3 receptor antagonist widely used as an antiemetic, has been reported to have positive effects on mood disorders. Adolescence is a critical period during the development of brain, where exposure to chronic stress during this time is highly associated with the development of depression. In this study, we showed that 4 weeks of juvenile social isolation stress (SIS) provoked depressive-like behaviors in male mice, which was associated with disruption of mitochondrial function and nitric oxide overproduction in the cortical areas. In this study, tropisetron (5mg/kg) reversed the negative behavioral effects of SIS in male mice. We found that the effects of tropisetron were mediated through mitigating the negative activity of inducible nitric oxide synthase (iNOS) on mitochondrial activity. Administration of aminoguanidine (specific iNOS inhibitor, 20mg/kg) augmented the protective effects of tropisetron (1mg/kg) on SIS. Furthermore, l-arginine (nitric oxide precursor, 100mg/kg) abolished the positive effects of tropisetron. These results have increased our knowledge on the pivotal role of mitochondrial function in the pathophysiology of depression, and highlighted the role of 5-HT3 receptors in psychosocial stress response during adolescence. Finally, we observed that tropisetron alleviated the mitochondrial dysfunction through decreased nitrergic system activity in the cerebral cortex.


Assuntos
Córtex Cerebral/efeitos dos fármacos , Indóis/farmacologia , Indóis/uso terapêutico , Nitratos/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Isolamento Social/psicologia , Estresse Psicológico/tratamento farmacológico , Animais , Animais Recém-Nascidos , Antidepressivos/farmacologia , Antidepressivos/uso terapêutico , Córtex Cerebral/metabolismo , Inibidores Enzimáticos/farmacologia , Comportamento Exploratório/efeitos dos fármacos , Masculino , Camundongos , Motivação/efeitos dos fármacos , NG-Nitroarginina Metil Éster/farmacologia , Nitrosação/efeitos dos fármacos , Espécies Reativas de Oxigênio/metabolismo , Estresse Psicológico/patologia , Tropizetrona
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA